| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,131,096 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 34
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
39,600 |
254,757 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-04-30 |
4 |
A |
$51.26 |
$46,547 |
D/D |
908 |
252,159 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2015-07-01 |
4 |
A |
$104.21 |
$13,235 |
D/D |
127 |
127 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2015-10-01 |
4 |
A |
$110.33 |
$14,453 |
D/D |
131 |
258 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2015-12-31 |
4 |
A |
$108.45 |
$14,424 |
D/D |
133 |
391 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
315,228 |
543,482 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
60,710 |
392,221 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2016-03-31 |
4 |
A |
$72.47 |
$14,494 |
D/D |
200 |
591 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2016-04-29 |
4 |
A |
$51.26 |
$21,223 |
D/D |
414 |
395,635 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2016-06-30 |
4 |
A |
$79.98 |
$14,476 |
D/D |
181 |
772 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2016-09-30 |
4 |
A |
$94.29 |
$14,426 |
D/D |
153 |
925 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2016-12-30 |
4 |
A |
$100.27 |
$14,439 |
D/D |
144 |
1,069 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
44,671 |
215,353 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
44,520 |
235,194 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-03-31 |
4 |
A |
$133.67 |
$14,436 |
D/D |
108 |
1,177 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
238,496 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-09-29 |
4 |
A |
$116.74 |
$14,476 |
D/D |
124 |
4,916 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2017-12-29 |
4 |
A |
$94.71 |
$14,491 |
D/D |
153 |
5,069 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,722 |
272,216 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
46,034 |
272,528 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
46,340 |
296,106 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-03-29 |
4 |
A |
$83.33 |
$14,499 |
D/D |
174 |
5,243 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
290,600 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-06-29 |
4 |
A |
$67.00 |
$14,472 |
D/D |
216 |
5,459 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2018-09-28 |
4 |
A |
$69.08 |
$14,438 |
D/D |
209 |
5,668 |
0 |
- |
|
850 Records found
|
|
Page 2 of 34 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
